Wai Chun Bio Technology : RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

瑋 俊 生 物 科 技 有 限 公 司

Wai Chun Bio-Technology Limited

(Incorporated in Cayman Islands with limited liability)

(Stock code: 0660)

RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR

The board of directors (the "Board") of Wai Chun Bio-Technology Limited (the "Company") hereby announces that on 14 September 2020, Mr. Li Jinyuan ("Mr. Li") has resigned as an Independent Non-executive Director, and ceased to be the member of Audit Committee of the Company.

Mr. Li has to resign from the Board as he wishes to devote more time to his personal commitments. Mr. Li has confirmed that he has no disagreement with the Board and is not aware of any matters in connection with his resignation that needs to be brought to the attention of The Stock Exchange of Hong Kong Limited and the shareholders of the Company.

The Board would like to take this opportunity to thank Mr. Li for his efforts and valuable contributions to the Company during his tenure of office and wishes them success in his future endeavours.

Following the resignation of Mr. Li, there is a vacancy in the position of the member of the Audit Committee of the Company and the Company only has two Independent Non-executive Directors, thus the number of Independent Non-executive Directors and number of the Audit Committee of the Company falls below the minimum number requirement under Rules 3.10(1) and 3.21 of the Rules Governing the Listing of Securities on the Stock Exchange (the "Listing Rules").

The Board will identify an appropriate person to fill the vacancy of Independent Non-executive Director and a member of the Audit Committee within three months from the date of resignation of Mr. Li pursuant to Rule 3.11 and Rule 3.23 of the Listing Rules. Further announcement will be made in relation to the appointment when appropriate.

1

By order of the Board

Wai Chun Bio-Technology Limited

LAM Ching Kui

Chairman and Chief Executive Officer

Hong Kong, 14 September 2020

As at the date of this announcement, the Board consists of one executive director, namely Mr. Lam Ching Kui (Chairman and Chief Executive Officer) and two independent non-executive directors, namely Mr. Hau Pak Man and Mr. Chan Chun Wai, Tony.

2